Zobrazeno 1 - 7
of 7
pro vyhledávání: '"CA Rowan"'
Publikováno v:
C65. PULMONARY HYPERTENSION ASSOCIATED WITH LUNG DISEASES OR OTHER ILLNESSES: PATHOGENESIS, DIAGNOSIS, AND CLINICAL OUTCOMES.
Publikováno v:
Circulation. 118
Introduction : Prior to the availability of oral/inhaled (inh) PAH drugs, i.e. 2001–2007, IV epoprostenol (EPO) was the only approved drug for pts un-responsive to calcium channel blockade (CCB). We report our experience transitioning selected pedi
Autor:
Zuckerman WA; Columbia University Medical Center, New York, New York, USA. wz2116@columbia.edu, Leaderer D, Rowan CA, Mituniewicz JD, Rosenzweig EB
Publikováno v:
The American journal of cardiology [Am J Cardiol] 2011 May 01; Vol. 107 (9), pp. 1381-5. Date of Electronic Publication: 2011 Mar 02.
Autor:
Melnick L; Division of Pediatric Cardiology, Columbia University College of Physicians and Surgeons, New York, New York, USA., Barst RJ, Rowan CA, Kerstein D, Rosenzweig EB
Publikováno v:
The American journal of cardiology [Am J Cardiol] 2010 May 15; Vol. 105 (10), pp. 1485-9. Date of Electronic Publication: 2010 Apr 08.
Autor:
Lucey JF; Department of Pediatrics, College of Medicine, University of Vermont, Burlington, Vermont 05405-0068, USA. jerold.lucey@uvm.edu, Rowan CA, Shiono P, Wilkinson AR, Kilpatrick S, Payne NR, Horbar J, Carpenter J, Rogowski J, Soll RF
Publikováno v:
Pediatrics [Pediatrics] 2004 Jun; Vol. 113 (6), pp. 1559-66.
Publikováno v:
American journal of public health [Am J Public Health] 1984 May; Vol. 74 (5), pp. 479-84.
Publikováno v:
Journal of environmental science and health. Part. B, Pesticides, food contaminants, and agricultural wastes [J Environ Sci Health B] 1984 Oct; Vol. 19 (7), pp. 611-48.